H K Chopra, Tiny Nair, C K Ponde, Subhash Kaul, Yatin Mehta, Agam Vora, Pinaki Mukhopadhyay, P B Jayagopal, Mrutyunjay Behera, Rahul Patil, Mahesh Deshpande, R Anantharaman
Coronavirus disease 2019 (COVID-19) is a highly hypercoagulable viral infection complicated as COVID-inflicted coagulopathy (CIC), that is associated with increased risk of morbidity and mortality. International guidelines recommend low molecular weight heparin (LMWH) to treat CIC in both in-hospital and in-home settings. However, in India, using subcutaneous LMWH may not be a feasible option for a vast majority of patients under home management. Additionally, while some evidence advocates the use of novel oral anticoagulants (NOACs), in hospitalized settings, most guidelines find no role of NOACs in hospital settings...
December 2022: Journal of the Association of Physicians of India